Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes

Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes

US Patent 8637563 · Granted Jan 28, 2014

Estimated economic value: $30,551,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of administration of thrombopoietin agonist compounds2013
Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells2013
Method of treating thrombocytopenia2013
Sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2012
Methods of use of sialoadhesin factor-2 antibodies2011
Thrombopoietin mimetics2010
Thrombopoietin mimetics2010
Sialoadhesin factor-2 antibodies2009
Thrombopoietin mimetics2009
Thrombopoietin mimetics2008
Thrombopoietin mimetics2008